Development and In Vitro Evaluation of Oral Capsules from <i>Antiaris</i>: A Convenient Substitute for Peripheral Neuropathy

<table class="table-group" id="tab5"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Formulation code</td><td class="align_center">Average absorbance</td><td class="align_center">Average drug content (%)</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">A01</td><td class="align_center">0.440 ± 0.008</td><td class="align_center">101.39 ± 0.099</td></tr><tr><td class="align_left">A02</td><td class="align_center">0.445 ± 0.059</td><td class="align_center">102.55 ± 0.042</td></tr><tr><td class="align_left">A03</td><td class="align_center">0.427 ± 0.071</td><td class="align_center">98.38 ± 0.015</td></tr><tr><td class="align_left">A04</td><td class="align_center">0.430 ± 0.035</td><td class="align_center">99.07 ± 0.021</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Comparative percentage content of <i>Antiaris africana</i> extract in capsules (<i>n</i> = 3).</div>

Advances in Pharmacological and Pharmaceutical Sciences

tab5

Table 5

Table 5: Development and In Vitro Evaluation of Oral Capsules from <i>Antiaris</i>: A Convenient Substitute for Peripheral Neuropathy 

Advances in Pharmacological and Pharmaceutical Sciences

Development and In Vitro Evaluation of Oral Capsules from Antiaris: A Convenient Substitute for Peripheral Neuropathy

Table 5